TrialBMJ open2019

Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study.

Tadashi Kamei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.